BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Desmosterol

An intermediate in the synthesis of cholesterol.

300+ PubMed studies analyzed · 8 RCTs · Evidence Score: 47.1

Research Domains

Desmosterol has been studied across 20 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫁 Liver & Detox, 🧠 Neuroprotection, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 76% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Desmosterol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

24s25
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
cyanidin
2 shared targets
lxr
2 shared targets
t091317
3 shared targets
alitretinoin
3 shared targets
bexarotene
2 shared targets
Bosentan
2 shared targets
Gemfibrozil
2 shared targets
Loading evidence profile...

This evidence profile for Desmosterol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.